Published on March 31, 2009
CERTIFICATIONS
OF THE PRINCIPAL EXECUTIVE OFFICER AND
PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18
U.S.C. SECTION 1350
In
connection with the Annual Report of Lixte Biotechnology Holdings, Inc. (the
“Company”) on Form 10-K for the year ended December 31, 2008, as filed with the
Securities and Exchange Commission (the “Report”), the undersigned does hereby
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that, to the best of the undersigned's
knowledge:
(i) The
Report fully complies with the requirements of Section 13(a) or Section 15(d),
as applicable, of the Securities Exchange Act of 1934, as amended;
and
(ii) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
|
Date: March
30, 2009
|
By:
|
/s/ John S. Kovach
|
|
John
S. Kovach
|
||
|
Chief
Executive Officer and
|
||
|
Chief
Financial Officer
|